BCL2L11 and acute lymphoblastic leukemia: By generating CCRF-CEM subclones that were either wildtype, heterozygous or homozygous for the BIM polymorphism, we were able to demonstrate that the BIM deletion polymorphism is able to confer GC resistance in a T-ALL cell line.